Insights

Innovative Therapeutics Creyon Bio specializes in developing RNA-targeted oligonucleotide therapies, positioning it at the forefront of personalized medicine and offering opportunities for partnerships, licensing, or supply chain solutions in the growing biotech and pharma sectors.

Strategic Collaborations The recent partnership with Eli Lilly valued over 1 billion dollars highlights Creyon Bio’s strong industry recognition and potential for joint development opportunities, making it a prime target for vendors offering clinical research, diagnostic tools, or bioprocessing services.

Funding Momentum With secured investments of over 40 million dollars and significant funding rounds, Creyon Bio is expanding its research and development capabilities, creating opportunities for technology providers, laboratory equipment suppliers, and innovation-focused service partners.

Leadership Expansion The appointment of industry leaders like Serge Messerlian as CEO and Shaquille Vayda to the board signals a strategic move towards growth and innovation, making the company receptive to executive-level consulting, strategic partnerships, and customized enterprise solutions.

Technology Ecosystem Utilizing a tech stack that includes Google Cloud Platform and Illumina sequencing technologies, Creyon Bio is likely to seek advanced digital solutions, cloud services, and bioinformatics tools to accelerate drug discovery and product development efforts.

Creyon Bio Tech Stack

Creyon Bio uses 8 technology products and services including RSS, Illumina, Shopify, and more. Explore Creyon Bio's tech stack below.

  • RSS
    Content Management System
  • Illumina
    Data Management
  • Shopify
    E-commerce
  • Google Cloud Platform
    Infrastructure As A Service
  • WP Engine
    Platform As A Service
  • JavaScript
    Programming Languages
  • Linux
    Programming Languages
  • HTTP/3
    Web & Portal Technology

Media & News

Creyon Bio's Email Address Formats

Creyon Bio uses at least 1 format(s):
Creyon Bio Email FormatsExamplePercentage
First@creyonbio.comJohn@creyonbio.com
86%
FLast@creyonbio.comJDoe@creyonbio.com
8%
Last@creyonbio.comDoe@creyonbio.com
4%
FirstL@creyonbio.comJohnD@creyonbio.com
2%

Frequently Asked Questions

Where is Creyon Bio's headquarters located?

Minus sign iconPlus sign icon
Creyon Bio's main headquarters is located at San Diego, California 92121 United States. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Creyon Bio's official website and social media links?

Minus sign iconPlus sign icon
Creyon Bio's official website is creyonbio.com and has social profiles on LinkedInCrunchbase.

What is Creyon Bio's NAICS code?

Minus sign iconPlus sign icon
Creyon Bio's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Creyon Bio have currently?

Minus sign iconPlus sign icon
As of February 2026, Creyon Bio has approximately 45 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Executive Director, Head Of India Operations: J. S.Svp, Head Of Research: M. L.Senior Director, Clinical Development: M. P.. Explore Creyon Bio's employee directory with LeadIQ.

What industry does Creyon Bio belong to?

Minus sign iconPlus sign icon
Creyon Bio operates in the Pharmaceutical Manufacturing industry.

What technology does Creyon Bio use?

Minus sign iconPlus sign icon
Creyon Bio's tech stack includes RSSIlluminaShopifyGoogle Cloud PlatformWP EngineJavaScriptLinuxHTTP/3.

What is Creyon Bio's email format?

Minus sign iconPlus sign icon
Creyon Bio's email format typically follows the pattern of First@creyonbio.com. Find more Creyon Bio email formats with LeadIQ.

How much funding has Creyon Bio raised to date?

Minus sign iconPlus sign icon
As of February 2026, Creyon Bio has raised $40M in funding. The last funding round occurred on Mar 08, 2022 for $40M.

When was Creyon Bio founded?

Minus sign iconPlus sign icon
Creyon Bio was founded in 2019.

Creyon Bio

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

At Creyon, we are redefining what’s possible in RNA drug design.

Creyon is an AI-driven drug development company creating tissue-specific, RNA-targeted nucleic acid therapies that are designed to be safer, more effective, and easier for patients to stay on. Our focus is on conditions where current RNA therapies face barriers to delivery and tolerability, including neuromuscular, central nervous system (CNS), and immunology disorders.

Our mission is to unlock the full therapeutic potential of RNA medicines through intelligent design, precise delivery, and a deep understanding of tissue biology enabling better outcomes and improved quality of life for patients.

Our vision is that the next generation of RNA medicines will be tissue-aware, computationally designed, and patient-centered, and we plan to lead that transformation bringing precision, predictability, and accessibility to RNA drug development.

Section iconCompany Overview

Headquarters
San Diego, California 92121 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $40M

    Creyon Bio has raised a total of $40M of funding over 1 rounds. Their latest funding round was raised on Mar 08, 2022 in the amount of $40M.

  • $10M$25M

    Creyon Bio's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $40M

    Creyon Bio has raised a total of $40M of funding over 1 rounds. Their latest funding round was raised on Mar 08, 2022 in the amount of $40M.

  • $10M$25M

    Creyon Bio's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.